(VIANEWS) – The NASDAQ opens in less than four hours and TherapeuticsMD‘s pre-market value is already 11.61% up.
The last session, NASDAQ Composite finished with TherapeuticsMD (TXMD) sliding 8.27% to $0.40. NASDAQ Composite fell 3.34% to $15,100.17, after two sequential sessions in a row of losses, on what was a very down trend exchanging session.
Volume
Today’s last reported volume for TherapeuticsMD is 8576060, 46.88% above its average volume of 5838545.
TherapeuticsMD’s last close was $0.40, 85.4% under its 52-week high of $2.75.
TherapeuticsMD’s Sales
TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the current quarter and the next is 16.7% and 40%, respectively.
TherapeuticsMD’s Revenue
Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.
TherapeuticsMD’s Stock Yearly Top and Bottom Value
TherapeuticsMD’s stock is valued at $0.40 at 05:56 EST, way under its 52-week high of $2.75 and higher than its 52-week low of $0.37.
TherapeuticsMD’s Moving Average
TherapeuticsMD’s value is way below its 50-day moving average of $0.66 and way under its 200-day moving average of $1.00.
More news about TherapeuticsMD (TXMD).
